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Volume 59, Number 6 Abstracts 1751wound healing or amputation rates. Two trials with unknown ulcer types
reported beneﬁcial effects on amputation rates, although the largest trial
used a different deﬁnition for both outcomes. HBOT did not inﬂuence
the need for additional interventions.
Conclusion: Current evidence shows some evidence of the effective-
ness of HBOT in improving the healing of diabetic leg ulcers in patients
with concomitant ischaemia. Larger trials of higher quality are needed
before implementation of HBOT in routine clinical practice in patients
with diabetic foot ulcers can be justiﬁed.
Optimising Treatment Parameters for Radiofrequency Induced
Thermal Therapy (RFiTT): A Comparison of the Manufacturer's
Treatment Guidance With a Locally Developed Treatment Protocol
Newman J.E., Meecham L., Walker R.J., Nyamekye I.K. Eur J Vasc
Endovasc Surg 2014;47:664-9.
Objective: Radiofrequency induced Thermal Therapy (RFiTT) is an
established endovenous device for the treatment of varicose veins. Our
aim was to compare the manufacturer's treatment guidance with a locally
developed treatment protocol on early truncal ablation rates between two
patient cohorts.
Methods: The study was a retrospective analysis of prospectively
collected data from 534 patients treated for incompetent truncal saphenous
veins between June 2009 and December 2012. Patients were treated either
according to the manufacturer's guidance (Treatment 1), a single pullback
rate of $1.5 s/cm, or according to local protocol (Treatment 2), repeated
vein treatment to visibly occlude the vein lumen. Follow-up at 6 weeks and
12 months included duplex examination, assessment of complications, and
pain scores for the ﬁrst postoperative week.
Results: 14 patients did not attend follow-up, leaving 98 patients (142
saphenous trunk treatments) who received Treatment 1 and 422 patients
(566 saphenous trunk treatments) who received Treatment 2. The two
groups were well matched for age, sex, and preoperative vein parameters.
Six week occlusion rates were signiﬁcantly different, with more treatment fail-
ures after Treatment 1 (Treatment 1 5.6% vs. Treatment 2 0.9%; P = .0001).
Treatment 1 was more likely to produce incomplete ablation (3.5% vs. 0.9%)
and non-ablation (2.1% vs. 0.0%) compared with Treatment 2. No major
complications occurred in either group and functional outcomes wereotherwise comparable between the two treatment methods. Longer-term
follow-up at 12 months in the ﬁrst 100 patients undergoing Treatment 2
demonstratedmaintenance of the early advantage, with partial recanalisations
in 9% and 2% for Treatments 1 and 2, respectively.
Conclusions: Six weeks after treatment with RFiTT, a protocol of
repeated vein treatments to visibly obliterate the vein lumen produced
more reliable venous occlusion compared with manufacturer's guidance.
This advantage is maintained at 12 months.
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Objective: Superﬁcial venous reﬂux and varicose veins are com-
mon. The aim of this randomized controlled trial was to assess effective-
ness of compression therapy compared with surgery for superﬁcial
venous reﬂux.
Methods: 153 patients with CEAP class C2eC3 and superﬁcial
venous reﬂux were randomized to receive either conservative treatment
(compression stockings) (n = 77) or surgery (n = 76). Clinical examination
including duplex ultrasound (DUS) was performed at entry and 1 and 2
years after randomization (compression group) or surgery (surgery group).
Venous Clinical Severity Score without compression stockings (VCSS-S),
Venous Segmental Disease Score (VSDS), Venous Disability Score (VDS),
and health-related quality of life (HRQoL) were assessed at entry and at
the follow-ups. Data were analysed on an intention-to-treat basis and
according to the actual treatment performed.
Results: At 2 years, 70/76 patients in the surgery group and 11/77
patients in the compression group had been operated on. VCSS-S decreased
from 4.6 to 3.5 in the compression group (P < .01) and from 4.8 to 0.6 in
the surgery group (P < .001). VSDS decreased from 7.7 to 7.0 in the
compression group and from 8.2 to 0.9 in the surgery group (P <
.0001). HRQoL did not change in the compression group, but improved
signiﬁcantly in the surgery group.
Conclusion: The surgical elimination of non-complicated superﬁcial
venous reﬂux is an effective treatment when compared with providing
compression stockings only.
